John McCoy
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
John A. McCoy is President & Treasurer at Cardiovascular Systems, Inc. and Vice President-Finance & Controller at Abbott Laboratories since 2023.
Formerly, Mr. McCoy was Senior Vice President & Controller at Baxalta, Inc. from 2015 to 2016.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/03/2026 | 24.686 ( 0 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | Presidente | - |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01/09/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| BAXALTA INC | Comptroller/Controller/Auditor | 01/01/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Develops medical devices for treating peripheral and coronary artery disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.